期刊文献+

血糖波动性的临床意义及其干预研究 被引量:15

Glucose fluctuation and intervention in its clinical significance
下载PDF
导出
摘要 糖尿病慢性并发症的发生、发展不仅与整体血糖水平相关,而且与血糖波动性有密切关系。血糖大幅波动可能通过激发多种代谢途径而导致微血管和大血管损伤。临床造成糖尿病患者血糖波动过大的主要原因有两个:未经合理控制的餐后高血糖和治疗不当导致的低血糖。α-葡萄糖苷酶抑制剂、格列萘类胰岛素促泌剂及速效、长效人胰岛素类似物等新剂型的出现,使糖尿病的治疗更加精细和安全,血糖控制更加严格和平稳,为减少血糖波动提供了有力武器。 The initiation and development of diabetic chronic complications is associated not only with the level of blood glucose, but also with the glucose fluctuation. The damage in large artery and microvessel may be caused by glucose fluctuation. There are two causes which induce glucose fluctuation in clinical:one is postprandial hyperglyceamia with not well controlled, the other is hypoglycemia causes by unsuitable therapy. A lot of effective new types of substances were applicated in clinical, such as α- glucosidase inhibitor, glinide-insulin secretagogus, fast-acting and long-acting insulin analogues. With these new powerful tools, there is possibility to treat diabetes more correctly and safely, and control the blood glucose in a stable and good level.
作者 王燕燕
出处 《医学研究生学报》 CAS 2007年第7期766-769,共4页 Journal of Medical Postgraduates
基金 全军"十五"卫生科研基金资助项目(批准号:01MB022)
关键词 糖尿病 血糖 波动性 Diabetes mellitus Blood glucose Fluctuation
  • 相关文献

参考文献12

  • 1Hirsch IB.Glycemic variability:it's not just about HbA1c anymore[J].Diabetes Technol Ther,2005,7(5):780-783.
  • 2Del Prato S.In search of normoglycaemia in diabetes:controlling postprandial glucose[ J].Int J Obes Relat Metab Disord,2002,26(Suppl):S9-S17.
  • 3American Diabetes Association.Postprandial blood glucose[J].Diabetes Care,2001,24(4):775-778.
  • 4Jones SC,Saunders HJ,Qi W,et al.Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cell[ J ].Diabetologia,1999,42 (9):1113-1119.
  • 5刘江华,宓宝斌,廖二元,柏勇平,刘宗汉,全智华,文格波.波动性高糖对内皮细胞血管舒张因子合成的影响[J].中国动脉硬化杂志,2006,14(1):55-56. 被引量:40
  • 6Ghanim H,Aljada A,Hofmeyer D,et al.Circulating mononuclear cells in the obese are in a proinflammatory state[ J ].Circulation,2004,110(12):1564-1571.
  • 7Quagliaro L,Piconi L,Assaloni R,et al.Intermittent high glucose enhances ICAM-1,VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture:the distinct role of protein kinase C and mitochondrial superoxide production[ J ].Atherosclerosis,2005,183 (2):259-267.
  • 8王燕燕,王晓,赵明,陆邦超,顾萍,卢斌,李洁,王杨天,邵加庆.2型糖尿病患者肾小管间质改变的临床研究[J].医学研究生学报,2005,18(5):417-420. 被引量:2
  • 9The DECODE study group.Glucose tolerance and mortality:comparison of WHO and American Diabetes Association diagnostic criteria[ J ].Lancet,1999,354 (9179):617-621.
  • 10Temelkova-Kurktschiev TS,Koehler C,Henkel E,et al.Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level[J].Diabetes Care,2000,23 (12):1830-1834.

二级参考文献25

  • 1李赟,刘江华.波动性高血糖与糖尿病大血管并发症[J].国外医学(内分泌学分册),2004,24(6):400-401. 被引量:29
  • 2姚瑞,党瑜华,张菲斐.非对称性二甲基精氨酸对人脐静脉内皮细胞功能的影响[J].中国动脉硬化杂志,2005,13(4):471-474. 被引量:6
  • 3[1]Weyer C,Bogardus C,Mott DM,et al.The nataral history of insulin secretory dysfunction and insulin resistence in the pathogenesis of type 2 diabetes mellitus.J Clin Invest,1999,104:787-794.
  • 4[2]Porte D,Kahn SE.β cell dysfunction and failure in type 2 diabetes:potential mechanisms.Diabetes,2001,50(suppl 1):s160-s163.
  • 5[3]Del Prato S,Tiengo A.The importance of first-phase inswlin secretion:implications for the therapy of type 2 diahetes mellitus.Diabetes Metab Res Rev,2001,17:164-174.
  • 6[4]Luzi L,DeFronzo RA.Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose diposal in humans.Am J Physiol,1989,257(2pt 1):E241-E246.
  • 7[5]Haffner SM.The importance of hyperglycaemia in the nonfasting state to the development of cardiovascular disease.Endocr Rey,1998,19:583-592.
  • 8[6]Tominaga M,Igarishi K,Eguchi H,et al.Impaired glucose tolerance is a risk factor for cardiovascular disease,but not impaired fasting glucose.Diabetes Care,1999,22:920-924.
  • 9[7]Massi-Benedetti M,Damsbo P.Pharmaeology and clinical experience with Repaglinide.Expert Opinion on Investigational Drugs,2000,9:885-898.
  • 10[8]Owens DR.Repaglinide prandial glucose regulator:a new,class of oral antidiabetic drug.Diabet Med,1998,15(Suppl 4):S28-S26.

共引文献42

同被引文献132

引证文献15

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部